ClinicalTrials.gg
RecruitingNCT06978803DISCOURSE-NBUpdated May 18, 2025

HYEEG Discourse in Psychosis: A Neurobehavioural Study

An observational study in Psychosis and Schizophrenia Disorders, sponsored by Douglas Mental Health University Institute. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-18.

Sponsored by Douglas Mental Health University Institute · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
110
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Psychotic Disorders by Douglas Mental Health University Institute — 7 open to participants now, 7 under way, none of them phase 3. Psychotic Disorders · Douglas Mental Health University Institute.

Started
2024
with 3 others
Observational
6 of 12
5 open now
Registered
7th of 12
by date

Among the 12 studies in Psychotic Disorders by Douglas Mental Health University Institute, this one is one of 4 that started in 2024, is one of 6 observational ones, and was the 7th registered.

Psychotic Disorders

1,593 studies on the registry are indexed under Psychotic Disorders; 283 are open to participants now.

Browse Psychotic Disorders studies →

Open to participants now

7 of the 12 studies in Psychotic Disorders by Douglas Mental Health University Institute are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 204 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 142 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Psychotic Disorders by Douglas Mental Health University Institute, or all of them as a file.
02

Study summary

This multimodal study explores the mechanisms underlying social dysfunction in individuals with schizophrenia. It focuses on the relationship between disorganized communication and social interaction, aiming to identify measurable markers of disorganized communication and link them to clinical symptoms and social functioning.

Key Research Questions:

How do neural and behavioural synchrony contribute to social impairments in schizophrenia?

What roles do interbrain synchrony, motor imitation, reaction time, and verbal coherence play in disorganized communication?

Participants will:

  1. Engage in structured and semi-structured real-time social interactions while undergoing dual-brain electroencephalogram (EEG) hyperscanning to measure neural and behavioural activity.
  2. Perform nonverbal tasks such as motor imitation and reaction time assessments to investigate coordination and behavioural synchrony patterns.
  3. Participate in a clinical interview that evaluates verbal production, thought coherence, and speech organization.

By combining these assessments, the study aims to advance our understanding of how social and communication impairments manifest in schizophrenia. The findings will contribute to developing improved diagnostic tools and targeted interventions, ultimately supporting patients in achieving better social functioning and quality of life.

Read the detailed description

INTRODUCTION

Schizophrenia, often associated with psychosis, is a severe mental disorder that profoundly impacts individuals, families, and society, diminishing quality of life and well-being globally. Disorganized communication-a hallmark feature of schizophrenia-is characterized by impairments in speech production, gesture-speech coordination, and motor behaviours that disrupt the ability to convey and interpret meaning in social contexts. These deficits profoundly undermine interpersonal relationships and social connectedness, creating barriers to meaningful social engagement. The impact of these challenges is particularly acute among marginalized populations, who face additional systemic obstacles such as stigma, reduced access to healthcare, and limited social support networks.

The early onset of psychosis, typically during late adolescence or early adulthood, coincides with a critical developmental period marked by heightened neuroplasticity. Social preferences, communication patterns, and adaptive behaviours are formed during this period. This developmental window is particularly vulnerable to disruptions in social interactions, which can derail neurobehavioural trajectories and contribute to long-term social dysfunction. Understanding how disorganized communication emerges and persists during this critical window is essential for designing early interventions to mitigate its effects.

Social disconnection-the breakdown of interpersonal connectivity and adaptability-is likely rooted in disruptions to the underlying neurobehavioural dynamics that facilitate coordinated interpersonal interactions. These dynamics include synchrony in speech, movement, and neural activity, which are crucial for effective social functioning. Despite significant advancements in mental health research, the specific neural and behavioural underpinnings of disorganized communication remain poorly understood, particularly in their relationship to broader social dysfunction in schizophrenia.

Addressing these challenges requires advanced tools capable of capturing the dynamic and reciprocal processes underlying social interactions. Real-time electroencephalogram (EEG) hyperscanning offers a robust method for studying interbrain synchrony, a critical interpersonal dynamic essential for coordinated social behaviour. This technique allows for the simultaneous recording of brain activity from two individuals engaged in reciprocal sensorimotor interactions, such as cooperative imitation. By analyzing patterns of synchrony and desynchrony in interbrain activity and associated bodily dynamics, EEG hyperscanning provides a detailed framework for examining the mechanisms underlying nonverbal communication and its disruptions.

This study integrates a speech elicitation protocol with standardized transcription methods and natural language processing (NLP) techniques developed by the Diverse International Scientific Consortium for Research in Thought, Language and Communication in Psychosis group. Additionally, it incorporates a validated motor imitation protocol from prior research with healthy participants. By combining EEG hyperscanning data with detailed analyses of verbal and nonverbal behaviours, the study seeks to identify disruptions in cooperative imitation and their links to speech disorganization, providing new insights into the mechanisms of disorganized communication.

This research aims to elucidate the mechanisms underlying disorganized communication by linking neural synchrony to verbal coherence, motor synchrony, and other neurobehavioural responses. These findings aim to inform the development of targeted early interventions that address both the behavioural and neural dimensions of disorganized communication in individuals with psychosis.

RATIONALE

The frontal and temporoparietal brain regions play critical roles in selective attention, inhibitory control, and social cognition. In schizophrenia, disruptions in neural synchronization between these regions-particularly within the alpha (8-12 Hz), beta (13-30 Hz), and gamma (30-100 Hz) frequency bands-are well-documented. Impaired functional connectivity between the prefrontal cortex and temporoparietal regions may contribute to maladaptive, self-focused attention, impairing the processing and integration of external social cues.

Specific dysregulations are hypothesized to underlie these deficits: alpha-band disruptions weaken attentional filtering, beta-band abnormalities impair sustained cognitive control, and gamma-band deficits disrupt the integration of social and perceptual information. These disruptions are expected to create an imbalance between internal and external processing, reducing neural coherence and phase synchronization during social exchanges. This breakdown in neural and behavioural coordination is hypothesized to manifest as neurobehavioural markers of disorganized communication-a hallmark feature of schizophrenia.

SPECIFIC HYPOTHESES

  1. Impairments in Inhibition-Based Imitation:

    Patients with schizophrenia will exhibit significant impairments in inhibition-based imitation compared to automatic imitation, as the former requires higher cognitive control. These impairments are expected to reflect deficits in executive function, particularly the ability to selectively suppress automatic responses.

  2. Correlation Between Imitation and Speech Disorganization:

    Difficulties in inhibition-based imitation will positively correlate with the severity of speech disorganization. Speech disorganization will be measured through clinical evaluations, structured interviews, and natural language processing (NLP) analyses, highlighting shared neural mechanisms underlying executive function and social communication.

  3. Reduced Interbrain Synchrony:

Interbrain synchrony during interpersonal coordination, assessed using EEG hyperscanning and behavioural analysis, will be significantly reduced in patients compared to healthy controls. This reduction is expected to reflect disruptions in neural oscillations critical for effective social interaction.

MULTIMODAL ANALYSES AND FUTURE DIRECTIONS

This research employs multimodal exploratory analyses to investigate the relationships between interbrain synchrony, bodily activity measures, and conversational speech variables, such as verbal coherence and semantic similarity. These analyses will also explore how these measures relate to symptom severity, providing a comprehensive understanding of their interplay.

By quantifying the effect sizes of these relationships, the study aims to establish foundational evidence for the development of larger-scale research. The results are expected to inform the refinement of experimental protocols, identify robust biomarkers of social dysfunction, and guide the design of targeted early interventions for individuals with psychosis.

03

Conditions studied

  • Psychosis
  • Schizophrenia Disorders

Keywords

  • hyperscanning eeg
  • psychosis
  • imitation tasks
  • interbrain synchrony
  • motor imitation
  • motor behaviour
  • speech disorganization
  • natural language processing
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with psychosis will be recruited from the following Douglas Mental Health University Institute areas: l'Étape Outpatient Clinic, Assertive Community Treatment Clinics, Intensive Psychosocial Rehab Clinic, and the Prevention and Early Intervention Program for Psychosis (PEPP) clinics in CIUSSS de l'ouest-de-L'île-de-Montréal, in association with the Centre for Youth Mental Health at the Douglas. Healthy Control participants will be recruited from the Greater Montreal Area using online study advertisements (Facebook, Kijiji, Twitter) and research study posters placed on bulletin boards.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. English or French-speaking participants (as dyads matched for language preference).
  2. Ages 18-60 years.
  3. Patients meeting the operational criteria for schizophrenia or schizoaffective illness as previously diagnosed by their treating psychiatrist, based on the (DSM) 5 criteria (Zipursky et al., 2020).
  4. Patients with less than 5 years of illness onset, based on the time of starting treatment with antipsychotic medication.

Exclusion criteria

Exclusion Criteria:

  1. Participants should not have a primary diagnosis of Alcohol or Drug abuse or addiction (however, co-morbid substance abuse with a primary diagnosis of psychotic disorder is not an exclusion criterion).
  2. Participants should not have a severe medical disorder that would explain psychotic symptoms.
  3. Participants should not have a past or current history of a primary neurological disorder that can affect speech output
  4. Participants with IQ below 70 or a concurrent pervasive developmental disorder (e.g., autism) will also be excluded.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
110 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthy controls

    1. English or French-speaking participants (as dyads matched for language preference). 2. Ages 18-60 years. 3. No diagnosis of schizophrenia or schizoaffective illness based on the Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 criteria.

  • Patients

    1. English or French-speaking participants (as dyads matched for language preference). 2. Ages 18-60 years. 3. Patients meeting the operational criteria for schizophrenia or schizoaffective illness as previously diagnosed by their treating psychiatrist, based on the Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 criteria. 4. Patients with less than 5 years of illness onset, based on the time of starting treatment with antipsychotic medication.

06

What researchers measure

Primary outcomes

  1. Inter-brain phase synchronization using Phase Locking Index via hyperscanning during communication

    Using oscillatory and time-frequency analyses of electroencephalography (EEG) hyperscanning data, inter-brain synchronization will be calculated via phase locking value for both patients and control subjects. This value will be related to: (1) verbal data from clinical interviews analyzed using Natural Language Processing techniques, including sentiment analysis to assess emotional tone, coherence classification to evaluate logical flow, and semantic similarity analysis (2) nonverbal measures such as motor synchrony, imitation accuracy, and reaction time.

    Time frame: baseline

Other outcomes

  1. Composite Index of Severity as Measured by the Positive and Negative Syndrome Scale (PANSS), THought and Language Index and Social and Occupational Functioning (SOFAS)

    This composite outcome will be a single factor score; higher values will reflect more severe symptoms and poor social functioning. Lower values will reflect better functioning and less severe symptoms. This will be derived from factor analysis of Positive and Negative Syndrome Scale (PANSS), Social and Occupational Functioning Assessment Scale (SOFAS), and the scores from the Thought and Language Index (TLI) clinical interview. This will be related to the primary outcome measure.

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Rybarczyk, B., Social and Occupational Functioning Assessment Scale (SOFAS), in Encyclopedia of Clinical Neuropsychology, J.S. Kreutzer, J. DeLuca, and B. Caplan, Editors. 2011, Springer New York: New York, NY. p. 2313-2313.
  • Liechti S, Capodilupo G, Opler DJ, Opler M, Yang LH. A Developmental History of the Positive and Negative Syndrome Scale (PANSS). Innov Clin Neurosci. 2017 Dec 1;14(11-12):12-17. PubMed 29410932 ↗
  • Tang SX, Kriz R, Cho S, Park SJ, Harowitz J, Gur RE, Bhati MT, Wolf DH, Sedoc J, Liberman MY. Natural language processing methods are sensitive to sub-clinical linguistic differences in schizophrenia spectrum disorders. NPJ Schizophr. 2021 May 14;7(1):25. doi: 10.1038/s41537-021-00154-3. PubMed 33990615 ↗
  • Morgan SE, Diederen K, Vertes PE, Ip SHY, Wang B, Thompson B, Demjaha A, De Micheli A, Oliver D, Liakata M, Fusar-Poli P, Spencer TJ, McGuire P. Natural Language Processing markers in first episode psychosis and people at clinical high-risk. Transl Psychiatry. 2021 Dec 13;11(1):630. doi: 10.1038/s41398-021-01722-y. PubMed 34903724 ↗
  • Liddle PF, Ngan ET, Caissie SL, Anderson CM, Bates AT, Quested DJ, White R, Weg R. Thought and Language Index: an instrument for assessing thought and language in schizophrenia. Br J Psychiatry. 2002 Oct;181:326-30. doi: 10.1192/bjp.181.4.326. PubMed 12356660 ↗
  • Kinreich S, Djalovski A, Kraus L, Louzoun Y, Feldman R. Brain-to-Brain Synchrony during Naturalistic Social Interactions. Sci Rep. 2017 Dec 6;7(1):17060. doi: 10.1038/s41598-017-17339-5. PubMed 29213107 ↗
  • Dumas G, Nadel J, Soussignan R, Martinerie J, Garnero L. Inter-brain synchronization during social interaction. PLoS One. 2010 Aug 17;5(8):e12166. doi: 10.1371/journal.pone.0012166. PubMed 20808907 ↗
  • Czeszumski A, Eustergerling S, Lang A, Menrath D, Gerstenberger M, Schuberth S, Schreiber F, Rendon ZZ, Konig P. Hyperscanning: A Valid Method to Study Neural Inter-brain Underpinnings of Social Interaction. Front Hum Neurosci. 2020 Feb 28;14:39. doi: 10.3389/fnhum.2020.00039. eCollection 2020. PubMed 32180710 ↗
  • Carollo A, Esposito G. Hyperscanning literature after two decades of neuroscientific research: A scientometric review. Neuroscience. 2024 Jul 23;551:345-354. doi: 10.1016/j.neuroscience.2024.05.045. Epub 2024 Jun 10. PubMed 38866073 ↗
  • Hirano Y, Uhlhaas PJ. Current findings and perspectives on aberrant neural oscillations in schizophrenia. Psychiatry Clin Neurosci. 2021 Dec;75(12):358-368. doi: 10.1111/pcn.13300. Epub 2021 Oct 29. PubMed 34558155 ↗
  • Geng JJ, Vossel S. Re-evaluating the role of TPJ in attentional control: contextual updating? Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2608-20. doi: 10.1016/j.neubiorev.2013.08.010. Epub 2013 Aug 30. PubMed 23999082 ↗
  • daSilva EB, Wood A. How and Why People Synchronize: An Integrated Perspective. Pers Soc Psychol Rev. 2025 May;29(2):159-187. doi: 10.1177/10888683241252036. Epub 2024 May 21. PubMed 38770754 ↗
  • Liu T, Pelowski M. Clarifying the interaction types in two-person neuroscience research. Front Hum Neurosci. 2014 Apr 30;8:276. doi: 10.3389/fnhum.2014.00276. eCollection 2014. No abstract available. PubMed 24817848 ↗
  • Nowak A, Vallacher RR, Zochowski M, Rychwalska A. Functional Synchronization: The Emergence of Coordinated Activity in Human Systems. Front Psychol. 2017 Jun 13;8:945. doi: 10.3389/fpsyg.2017.00945. eCollection 2017. PubMed 28659842 ↗
  • Koul A, Ahmar D, Iannetti GD, Novembre G. Interpersonal synchronization of spontaneously generated body movements. iScience. 2023 Feb 1;26(3):106104. doi: 10.1016/j.isci.2023.106104. eCollection 2023 Mar 17. PubMed 36852275 ↗
  • Bolis D, Dumas G, Schilbach L. Interpersonal attunement in social interactions: from collective psychophysiology to inter-personalized psychiatry and beyond. Philos Trans R Soc Lond B Biol Sci. 2023 Feb 13;378(1870):20210365. doi: 10.1098/rstb.2021.0365. Epub 2022 Dec 26. PubMed 36571122 ↗
  • Schilbach L. Towards a second-person neuropsychiatry. Philos Trans R Soc Lond B Biol Sci. 2016 Jan 19;371(1686):20150081. doi: 10.1098/rstb.2015.0081. PubMed 26644599 ↗
  • Green MF, Horan WP, Lee J. Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry. 2019 Jun;18(2):146-161. doi: 10.1002/wps.20624. PubMed 31059632 ↗
  • Gil-Berrozpe GJ, Peralta V, Sanchez-Torres AM, Moreno-Izco L, Garcia de Jalon E, Peralta D, Janda L, Cuesta MJ; SEGPEPs group. Psychopathological networks in psychosis: Changes over time and clinical relevance. A long-term cohort study of first-episode psychosis. Schizophr Res. 2023 Feb;252:23-32. doi: 10.1016/j.schres.2022.12.046. Epub 2023 Jan 6. PubMed 36621323 ↗
  • Rotenberg M, Tuck A, Anderson KK, McKenzie K. The Incidence of Psychotic Disorders and Area-level Marginalization in Ontario, Canada: A Population-based Retrospective Cohort Study. Can J Psychiatry. 2022 Mar;67(3):216-225. doi: 10.1177/07067437211011852. Epub 2021 Apr 26. PubMed 33896210 ↗
  • Jongsma HE, Turner C, Kirkbride JB, Jones PB. International incidence of psychotic disorders, 2002-17: a systematic review and meta-analysis. Lancet Public Health. 2019 May;4(5):e229-e244. doi: 10.1016/S2468-2667(19)30056-8. PubMed 31054641 ↗
  • Green MF, Horan WP, Lee J, McCleery A, Reddy LF, Wynn JK. Social Disconnection in Schizophrenia and the General Community. Schizophr Bull. 2018 Feb 15;44(2):242-249. doi: 10.1093/schbul/sbx082. PubMed 28637195 ↗
  • Correll CU, Solmi M, Croatto G, Schneider LK, Rohani-Montez SC, Fairley L, Smith N, Bitter I, Gorwood P, Taipale H, Tiihonen J. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry. 2022 Jun;21(2):248-271. doi: 10.1002/wps.20994. PubMed 35524619 ↗
  • Olarewaju E, Dumas G, Palaniyappan L. Disorganized Communication and Social Dysfunction in Schizophrenia: Emerging Concepts and Methods. Curr Psychiatry Rep. 2023 Nov;25(11):671-681. doi: 10.1007/s11920-023-01462-4. Epub 2023 Sep 23. PubMed 37740852 ↗
  • Cotter J, Granger K, Backx R, Hobbs M, Looi CY, Barnett JH. Social cognitive dysfunction as a clinical marker: A systematic review of meta-analyses across 30 clinical conditions. Neurosci Biobehav Rev. 2018 Jan;84:92-99. doi: 10.1016/j.neubiorev.2017.11.014. Epub 2017 Nov 24. PubMed 29175518 ↗
  • Gur RC, Gur RE. Social cognition as an RDoC domain. Am J Med Genet B Neuropsychiatr Genet. 2016 Jan;171B(1):132-41. doi: 10.1002/ajmg.b.32394. Epub 2015 Nov 26. PubMed 26607670 ↗
  • Porcelli S, Van Der Wee N, van der Werff S, Aghajani M, Glennon JC, van Heukelum S, Mogavero F, Lobo A, Olivera FJ, Lobo E, Posadas M, Dukart J, Kozak R, Arce E, Ikram A, Vorstman J, Bilderbeck A, Saris I, Kas MJ, Serretti A. Social brain, social dysfunction and social withdrawal. Neurosci Biobehav Rev. 2019 Feb;97:10-33. doi: 10.1016/j.neubiorev.2018.09.012. Epub 2018 Sep 20. PubMed 30244163 ↗
  • Kennedy DP, Adolphs R. The social brain in psychiatric and neurological disorders. Trends Cogn Sci. 2012 Nov;16(11):559-72. doi: 10.1016/j.tics.2012.09.006. Epub 2012 Oct 6. PubMed 23047070 ↗

Individual participant data

Plan to share: Yes — We propose to use a clinical linguistic archiving system called the TalkBank (https://www.talkbank.org/) for data sharing purposes. TalkBank registry/database is located at Carnegie Mellon University, Pittsburgh, Pennsylvania-USA. Several filters are used to de-identify the recorded speech data before storage in the databank. Firstly, the Discourse protocol explicitly avoids using proper nouns and names/addresses. Second, the transcribed data is checked, and any proper names are replaced by common names (e.g., 'McGill' will be changed to 'University') or bleeped out (for audio data). If requested, we will play back the recorded responses to check if the participant is comfortable with the degree of anonymity. Identifying demodemographics will not be stored alongside the speech data to reduce triangulation. Finally, sharing is controlled by password protection, and a re-review is done to remove identifying information before sharing is initiated.

Supporting information: Study protocol

Time frame: December 2028 for an unlimitied amount of time. There are no plans for data destruction of the study information stored (de-identified audio and transcriptions) within TalkBank.

Access criteria: The anonymized speech data will be retained on an access-controlled secure database hosted by TalkBank. We anticipate this being available within 2 years of the enrolment of the last participant. For more information see https://psychosis.talkbank.org/ and https://discourseinpsychosis.org/

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2024 (actual). Primary completion is estimated for Oct 2025, 21 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2025
First posted
May 18, 2025
StartActual
Jan 16, 2024
Primary completionEst.
Oct 22, 2025
CompletionEst.
Dec 31, 2026
Last update
May 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06978803
Lead sponsor
Douglas Mental Health University Institute
Responsible party
Lena Palaniyappan (Professor of Psychiatry, Douglas Mental Health University Institute) — Principal investigator
First posted
May 18, 2025
Start date
Jan 16, 2024
Primary completion
Oct 22, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 18, 2025

Study contacts

Emmanuel Olarewaju, PhD Candidate
Contact
emmanuel.olarewaju@mail.mcgill.ca
5147616131 ext. 2005
Lena Palaniyappan, MD, PhD
Contact
lena.palaniyappan@mcgill.ca
5147616131 ext. 6116
Lena Palaniyappan, MD, PhD
principal investigator · Douglas Mental Health University Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion